Product NDC: | 54868-2932 |
Proprietary Name: | Pristiq |
Non Proprietary Name: | desvenlafaxine succinate |
Active Ingredient(s): | 50 mg/1 & nbsp; desvenlafaxine succinate |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 54868-2932 |
Labeler Name: | Physicians Total Care, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021992 |
Marketing Category: | NDA |
Start Marketing Date: | 20080501 |
Package NDC: | 54868-2932-0 |
Package Description: | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (54868-2932-0) |
NDC Code | 54868-2932-0 |
Proprietary Name | Pristiq |
Package Description | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (54868-2932-0) |
Product NDC | 54868-2932 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | desvenlafaxine succinate |
Dosage Form Name | TABLET, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20080501 |
Marketing Category Name | NDA |
Labeler Name | Physicians Total Care, Inc. |
Substance Name | DESVENLAFAXINE SUCCINATE |
Strength Number | 50 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Norepinephrine Uptake Inhibitors [MoA],Serotonin and Norepinephrine Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA] |